Literature DB >> 17661663

Controlling gene expression in mycobacteria.

Sabine Ehrt1, Dirk Schnappinger.   

Abstract

The genus mycobacterium contains some of the most important human pathogens, including Mycobacterium tuberculosis, which causes tuberculosis in approximately 8 million people annually; Mycobacterium leprae, the etiologic agent of leprosy, which affects millions of people in Asia, Africa and Latin America; and Mycobacterium bovis, which causes tuberculosis in animals and people. Genetic tools for mycobacteria have been developed during the last 15 years and have helped to improve our understanding of the biology and pathogenesis of mycobacteria. However, genetic switches have only recently been developed that allow control of mycobacterial gene expression. Such systems have been used to facilitate protein overexpression in mycobacteria and to analyze gene function, in particular functions of essential genes. Some of the recently developed systems will allow controlling gene expression during animal infections and may therefore become invaluable tools for drug target validation. This article will review the features of available mycobacterial genetic switches and discuss their applications.

Entities:  

Mesh:

Year:  2006        PMID: 17661663     DOI: 10.2217/17460913.1.2.177

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  16 in total

1.  Improved mycobacterial tetracycline inducible vectors.

Authors:  Kerstin J Williams; Graham Joyce; Brian D Robertson
Journal:  Plasmid       Date:  2010-04-29       Impact factor: 3.466

2.  Mutational analysis of the mycobacteriophage BPs promoter PR reveals context-dependent sequences for mycobacterial gene expression.

Authors:  Lauren M Oldfield; Graham F Hatfull
Journal:  J Bacteriol       Date:  2014-08-04       Impact factor: 3.490

3.  The Mycobacterium tuberculosis regulatory network and hypoxia.

Authors:  James E Galagan; Kyle Minch; Matthew Peterson; Anna Lyubetskaya; Elham Azizi; Linsday Sweet; Antonio Gomes; Tige Rustad; Gregory Dolganov; Irina Glotova; Thomas Abeel; Chris Mahwinney; Adam D Kennedy; René Allard; William Brabant; Andrew Krueger; Suma Jaini; Brent Honda; Wen-Han Yu; Mark J Hickey; Jeremy Zucker; Christopher Garay; Brian Weiner; Peter Sisk; Christian Stolte; Jessica K Winkler; Yves Van de Peer; Paul Iazzetti; Diogo Camacho; Jonathan Dreyfuss; Yang Liu; Anca Dorhoi; Hans-Joachim Mollenkopf; Paul Drogaris; Julie Lamontagne; Yiyong Zhou; Julie Piquenot; Sang Tae Park; Sahadevan Raman; Stefan H E Kaufmann; Robert P Mohney; Daniel Chelsky; D Branch Moody; David R Sherman; Gary K Schoolnik
Journal:  Nature       Date:  2013-07-03       Impact factor: 49.962

4.  Recombinant reporter assay using transcriptional machinery of Mycobacterium tuberculosis.

Authors:  Rajdeep Banerjee; Paulami Rudra; Abinit Saha; Jayanta Mukhopadhyay
Journal:  J Bacteriol       Date:  2014-12-01       Impact factor: 3.490

5.  Silencing Mycobacterium smegmatis by using tetracycline repressors.

Authors:  Xinzheng V Guo; Mercedes Monteleone; Marcus Klotzsche; Annette Kamionka; Wolfgang Hillen; Miriam Braunstein; Sabine Ehrt; Dirk Schnappinger
Journal:  J Bacteriol       Date:  2007-05-04       Impact factor: 3.490

6.  The MprB extracytoplasmic domain negatively regulates activation of the Mycobacterium tuberculosis MprAB two-component system.

Authors:  Daniel J Bretl; Tarin M Bigley; Scott S Terhune; Thomas C Zahrt
Journal:  J Bacteriol       Date:  2013-11-01       Impact factor: 3.490

7.  In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice.

Authors:  Sheetal Gandotra; Dirk Schnappinger; Mercedes Monteleone; Wolfgang Hillen; Sabine Ehrt
Journal:  Nat Med       Date:  2007-12-02       Impact factor: 53.440

8.  Biochemical characterization of L1 repressor mutants with altered operator DNA binding activity.

Authors:  Amitava Bandhu; Tridib Ganguly; Biswanath Jana; Amritangshu Chakravarty; Anindya Biswas; Subrata Sau
Journal:  Bacteriophage       Date:  2012-04-01

9.  4'-Phosphopantetheinyl transferase PptT, a new drug target required for Mycobacterium tuberculosis growth and persistence in vivo.

Authors:  Cécile Leblanc; Thomas Prudhomme; Guillaume Tabouret; Aurélie Ray; Sophie Burbaud; Stéphanie Cabantous; Lionel Mourey; Christophe Guilhot; Christian Chalut
Journal:  PLoS Pathog       Date:  2012-12-20       Impact factor: 6.823

10.  An IPTG Inducible Conditional Expression System for Mycobacteria.

Authors:  Sudha Ravishankar; Anisha Ambady; Haripriya Ramu; Naina Vinay Mudugal; Ragadeepthi Tunduguru; Anand Anbarasu; Umender K Sharma; Vasan K Sambandamurthy; Sudha Ramaiah
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.